dehydration semaglutide Ozempic (Semaglutide): GLP-1 receptor agonist used for type 2 diabetes. It commonly causes dose-related gastrointestinal GLP-1 Weight Loss Drugs and

Hair loss is not widely discussed as a potential effect of GLP-1 therapy, yet it appeared repeatedly in the database

Trial data comparison shows the progression from single-agonist (semaglutide) to dual-agonist (tirzepatide) to triple-agonist (retatrutide) correlates with increasing weight loss efficacy

PlexusDx exclusively partners with 503A compounding pharmacies because this regulatory pathway provides direct accountability to state boards and requires individualized prescriber oversight

All authors read and approved the manuscript

While the active ingredient in Ozempic is Semaglutide, there are also a number of other ingredients and components that make up the injection solution and allergies to these additional ingredients could potentially cause issues

Tirzepatide is the active ingredient the molecule inside the pen